... now on. If that turns out to be the case, it could be a hindrance for pioneering fields such as Japan's stem cell research or development of new drugs. On Sept. 26, Health, Labor and Welfare Minister Norihisa Tamura summoned David Epstein, division ...
http://www.pharmpro.com/news/2013/10/novartis-drug-scandal-may-taint-japanese-clinical-research
http://www.pharmpro.com/news/2013/10/novartis-drug-scandal-may-taint-japanese-clinical-research
No comments:
Post a Comment